Do the motor manifestations of parkinson disease alter motor axon excitability?
β Scribed by Stacey K. Jankelowitz; David Burke
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 171 KB
- Volume
- 45
- Category
- Article
- ISSN
- 0148-639X
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Background: Axonal excitability is altered in common medical conditions such as stroke, multiple sclerosis, and spinal cord injury. Given the motor neuron changes in the presence of rigidity and tremor in Parkinson disease, we examine whether there are also changes in motor axon excitability. Methods: Axonal excitability studies were performed in 15 Parkinson subjects and 12 ageβmatched control subjects. Results: There was no significant difference in excitability indices between Parkinson subjects and control subjects. Conclusions: It is unlikely that the lack of change in the excitability indices reflects a balance between the effects of bradykinesia (βunderactivityβ) and the effects of rigidity and tremor (βoveractivityβ) on the motoneuron and its axon. It is more likely that plastic changes in motoneuron properties do not occur symmetrically with decreases and increases in activity, being more profound when activity levels are interrupted and less obvious when they are enhanced. Muscle Nerve 45: 43β47, 2012
π SIMILAR VOLUMES
## Abstract With prospects improving for experimental therapeutics aimed at postponing the onset of illness in preclinical carriers of the Huntington's disease (HD) gene, we assessed agreement among experienced clinicians with respect to the motor manifestations of HD, a relevant outcome measure fo
## Abstract To investigate whether there are interβnerve differences in the extent and pattern of axonal excitability changes produced by voluntary contractions of tibialis anterior (TA) and abductor pollicis brevis (APB), threshold tracking was used to measure axonal excitability parameters [thres
## Abstract In this prospective study of 34 patients with Parkinson's disease (PD), measurements of the short duration levodopa motor response have been performed every 3 years in defined __off__ states. The mean time from initiation of levodopa treatment was 14.8 years, and 17 patients survived to